ASCO Multiple Myeloma

Parameswaran Hari, MD, MRCP, Discusses Second Malignancies and Second Transplants in Multiple Myeloma Treatment
July 18, 2020

Parameswaran Hari, MD, MRCP, discussed second malignancies and second transplants for patients who stopped versus continued lenalidomide maintenance therapy to treat multiple myeloma from a follow-up trial presented at the 2020 ASCO Virtual Scientific Program.

Meletios A. Dimopoulos, MD, on the Future of a Combination Therapy in Multiple Myeloma
June 26, 2020

Meletios A. Dimopoulos, MD, discussed the reassuring aspects and future implications of the phase III Boston study examining a new combination therapy to treat patients with multiple myeloma.

CARTITUDE-1 Study Results Show Promise for Patients with Relapsed/Refractory Multiple Myeloma
June 13, 2020

Jesus G. Berdeja, MD, of the Sarah Cannon Research Institute discussed the CARTITUDE-1 study that examined CAR-T cell therapy to treat patients with relapsed/refractory multiple myeloma presented at the 2020 ASCO Virtual Scientific Program.